Silver-Coated Hip Megaprosthesis in Oncological Limb Savage Surgery

Table 2

Early infection, considered as evidence of infection which occurred before 6 months after first surgery, was lower in silver-coated prosthesis group. No difference was demonstrated between the two groups for late infection risk.

	Early infections	Late infections	Total
Silver-coated hip megaprostheses	1 (2.6%)	2 (5.3%)	3 (7.9%)
Titan uncoated hip megaprostheses	3 (10%)	2 (6.6%)	5 (16.7%)